Karla V. Ballman

Also affiliated with Cornell University, Alliance for Clinical Trials in Oncology, WinnMed, Mayo Clinic in Arizona, St. Luke's Hospital, Mayo Clinic in Florida, Weill Cornell Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 57 papers. Top paper: “Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma”.

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma

New England Journal of Medicine(2024)10.1056/nejmoa2401726

N/A

3.9DataRank · unranked

151 citations

Karla V. Ballman, Guru Sonpavde, Stephanie Berg, William Y. Kim, Rahul Atul Parikh +35 more

Prostate-Specific Membrane Antigen–Targeting Alpha Emitter via Antibody Delivery for Metastatic Castration-Resistant Prostate Cancer: A Phase I Dose-Escalation Study of 225Ac-J591

Journal of Clinical Oncology(2023)10.1200/jco.23.00573

N/A

2.6DataRank · unranked

69 citations

Charlene Thomas, Oliver Sartor, Michael Sun, Judith Stangl‐Kremser, Mahelia Bissassar +10 more

Multi-Institutional Prospective Validation of Prognostic mRNA Signatures in Early Stage Squamous Lung Cancer (Alliance)

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.07.005

N/A

1.5DataRank · unranked

41 citations

William G. Richards, David H. Harpole, Karla V. Ballman, Ming-Sound Tsao, Zhengming Chen +18 more

Association of urine mitochondrial DNA with clinical measures of COPD in the SPIROMICS cohort

JCI Insight(2020)10.1172/jci.insight.133984

N/A

1.5DataRank · unranked

43 citations

Michelle C. Rice, Katherine L. Hoffman, Clara Oromendia, Igor Barjaktarević, J. Michael Wells +22 more

Safety and efficacy of pembrolizumab, radiation therapy, and surgery versus radiation therapy and surgery for stage III soft tissue sarcoma of the extremity (SU2C-SARC032): an open-label, randomised clinical trial

The Lancet(2024)10.1016/s0140-6736(24)01812-9

N/A

1.4DataRank · unranked

84 citations

Karla V. Ballman, Angela Hong, Scott M. Schuetze, Andrew J. Wagner, Varun Monga +23 more

SARC025 arms 1 and 2: A phase 1 study of the poly(ADP‐ribose) polymerase inhibitor niraparib with temozolomide or irinotecan in patients with advanced Ewing sarcoma

Cancer(2020)10.1002/cncr.33349

N/A

1.4DataRank · unranked

47 citations

Karla V. Ballman, Lee J. Helman, Shreyaskumar Patel, Jeremy Whelan, Brigitte C. Widemann +9 more

Association of plasma mitochondrial DNA with COPD severity and progression in the SPIROMICS cohort

Respiratory Research(2021)10.1186/s12931-021-01707-x

N/A

1.0DataRank · unranked

31 citations

Katherine L. Hoffman, Kristen T. Schiffer, Clara Oromendia, Michelle C. Rice, Igor Barjaktarević +20 more

Alliance A011801 (compassHER2 RD): Postneoadjuvant T-DM1 + Tucatinib/Placebo in Patients with Residual HER2-Positive Invasive Breast Cancer

Future Oncology(2021)10.2217/fon-2021-0753

N/A

0.901DataRank · unranked

30 citations

Karla V. Ballman, Linda McCall, Anuhya Kommalapati, Tyler Zemla, Anna Weiss +12 more

Role of specialized composition of SWI/SNF complexes in prostate cancer lineage plasticity

Nature Communications(2020)10.1038/s41467-020-19328-1

N/A

0.752DataRank · unranked

149 citations

Anke Augspach, Maria Rosaria De Filippo, Davide Prandi, Phillip Thienger, Matteo Benelli +27 more

Association of circulating markers with cognitive decline after radiation therapy for brain metastasis

Neuro-Oncology(2022)10.1093/neuonc/noac262

N/A

0.572DataRank · unranked

17 citations

S. Keith Anderson, Karla V. Ballman, Erin Twohy, Katharine Dooley, Wen Jiang +20 more

A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas

Journal of Clinical Investigation(2022)10.1172/jci160767

N/A

0.494DataRank · unranked

26 citations

Inah Hwang, Heng Pan, Jun Yao, Lapo Alinari, Eddie L. Imada +19 more

Clinical Significance of Circulating Tumor Cells in Hormone Receptor–positive Metastatic Breast Cancer Patients who Received Letrozole with or Without Bevacizumab

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-1329

N/A

0.483DataRank · unranked

24 citations

Oleksandr Savenkov, Erik Asmus, Karla V. Ballman, Janet H. Scott, John W. Park +6 more

Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials

Nature Communications(2023)10.1038/s41467-023-42635-2

N/A

0.434DataRank · unranked

17 citations

Aranzazu Fernández-Martínez, David Venet, Françoise Rothé, Katherine A. Hoadley, Joel S. Parker +17 more

Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502

npj Breast Cancer(2024)10.1038/s41523-024-00683-x

N/A

0.419DataRank · unranked

7 citations

Roberto Salgado, Oleksander Savenkov, Karla V. Ballman, Erica L. Mayer, Mark Jesus M. Magbanua +11 more

MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients with metastatic urothelial cancer (mUC) (Alliance A032001).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4607

N/A

0.385DataRank · unranked

12 citations

Karla V. Ballman, Matt D. Galsky, Michael J. Morris, Ronald C. Chen, Timothy A. Chan +9 more

Effect of a telephone-based weight loss intervention (WLI) on weight at 12-months in women with early breast cancer: Results from the Breast Cancer Weight Loss (BWEL) trial.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.12001

N/A

0.360DataRank · unranked

10 citations

Karla V. Ballman, Linda McCall, Pamela J. Goodwin, Anna Weiss, Linda M. Delahanty +15 more

Adjuvant Dose-Dense Chemotherapy in Hormone Receptor–Positive Breast Cancer

Journal of Clinical Oncology(2025)10.1200/jco-24-01875

N/A

0.319DataRank · unranked

6 citations

Karla V. Ballman, Jordan D. Campbell, Minetta C. Liu, Jennifer A. Ligibel, Mark A. Watson +12 more

Randomized comparison of the clinical Outcome of single versus Multiple Arterial grafts: Quality of Life (ROMA:QOL) – Rationale and Study Protocol

European Heart Journal - Quality of Care and Clinical Outcomes(2021)10.1093/ehjqcco/qcab022

N/A

0.249DataRank · unranked

4 citations

Monika M. Safford, Karla V. Ballman, Annie Myers, Stephen E. Fremes, Mario Gaudino +1 more

Circulating Tumor DNA and Response to Cisplatin-based Chemotherapy in Patients with Metastatic Urothelial Carcinoma Enrolled in CALGB 90601 (Alliance)

European Urology Open Science(2025)10.1016/j.euros.2025.03.009

N/A

0.208DataRank · unranked

3 citations

Karissa Whiting, Ronak Shah, Karla V. Ballman, Susan Halabi, Ashley Marie Regazzi +10 more

Association of tumor infiltrating lymphocyte quantity with survival in patients (pts) with metastatic breast cancer (MBC) receiving microtubule-targeting agents: Post hoc analysis CALGB 40502 (Alliance).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.1010

N/A

0.203DataRank · unranked

2 citations

Roberto Salgado, Oleksandr Savenkov, Karla V. Ballman, Mark Jesus M. Magbanua, Sherene Loi +11 more

Association between molecular subtype membership or hypoxia-associated gene expression signatures and clinical outcomes in the CALGB 90601 (Alliance) phase 3 clinical trial of gemcitabine and cisplatin (GC) plus bevacizumab (B) or placebo (P).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4562

N/A

0.104DataRank · unranked

1 citations

Woonyoung Choi, Susan Halabi, Bin Luo, Hikmat Al‐Ahmadie, Jonathan E. Rosenberg +12 more

MAIN-CAV: Phase III randomized trial of maintenance cabozantinib and avelumab versus avelumab after first-line platinum-based chemotherapy in patients (pts) with metastatic urothelial cancer (mUC; Alliance A032001).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps4609

N/A

0.104DataRank · unranked

1 citations

Karla V. Ballman, Matt D. Galsky, Michael J. Morris, Srikala S. Sridhar, Ronald C. Chen +7 more

A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.36_suppl.360922

N/A

0DataRank · unranked

16 citations

Karla V. Ballman, Eric P. Winer, Thomas H. Openshaw, Olwen Hahn, Frederick Briccetti +10 more

Phase I/II trial of pembrolizumab and AR signaling inhibitor +/- 225Ac-J591 for chemo-naive metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.6_suppl.tps216

N/A

0DataRank · unranked

9 citations

Joseph R. Osborne, Matthew C. Dallos, Jones T. Nauseef, Cora N. Sternberg, Peter Gregos +11 more

Association of DNA damage repair (DDR) mutations (mts) and clinical outcomes in CALGB 90601 (Alliance).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.4521

N/A

0DataRank · unranked

0 citations

Susan Halabi, Bin Luo, Jonathan E. Rosenberg, Woonyoung Choi, Hikmat Al‐Ahmadie +12 more

Randomized Comparison of the Outcome of Single Versus Multiple Arterial Grafts trial (ROMA):Women—a trial dedicated to women to improve coronary bypass outcomes

Journal of Thoracic and Cardiovascular Surgery(2023)10.1016/j.jtcvs.2023.06.006

N/A

0DataRank · unranked

25 citations

C. Noel Bairey Merz, Sigrid Sandner, Ruth Masterson Creber, Karla V. Ballman, Sean M. O’Brien +6 more

Effect of Sepsis on Death as Modified by Solid Organ Transplantation

Open Forum Infectious Diseases(2023)10.1093/ofid/ofad148

N/A

0DataRank · unranked

20 citations

Katherine L Hoffman, Iván Díaz, Will Simmons, Karla V. Ballman, Rosy Priya Kodiyanplakkal +2 more

Age, Body Mass Index, Tumor Subtype, and Racial and Ethnic Disparities in Breast Cancer Survival

JAMA Network Open(2023)10.1001/jamanetworkopen.2023.39584

N/A

0DataRank · unranked

17 citations

Karla V. Ballman, Jordan D. Campbell, Hyman B. Muss, Edith A. Perez, Lawrence N. Shulman +4 more

Hyper-Dependence on NHEJ Enables Synergy between DNA-PK Inhibitors and Low-Dose Doxorubicin in Leiomyosarcoma

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0998

N/A

0DataRank · unranked

12 citations

Jan Novotný, D. Gulhan, Isabella Klooster, Antuan V. Tran, Macy Kasbo +17 more

SARC037: Results of phase I study of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in relapsed/refractory Ewing sarcoma (ES).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11519

N/A

0DataRank · unranked

14 citations

Karla V. Ballman, Rachel S. Heise, John Glod, Mary Frances Wedekind, Leo Mascarenhas +15 more

Alliance A032002 (ART): Phase II randomized trial of atezolizumab versus atezolizumab and radiation therapy for platinum-ineligible/refractory metastatic urothelial cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.6_suppl.tps589

N/A

0DataRank · unranked

1 citations

Karla V. Ballman, Scott T. Tagawa, Alan Tan, Bishoy M. Faltas, Arshin Sheybani +11 more

Data from A t(1;19)(q10;p10) Mediates the Combined Deletions of 1p and 19q and Predicts a Better Prognosis of Patients with Oligodendroglioma

(2023)10.1158/0008-5472.c.6494621

N/A

0DataRank · unranked

0 citations

Hilary Blair, Karla V. Ballman, Caterina Giannini, Robert M. Arusell, Mark E. Law +7 more

SARC037: Phase II results of trabectedin given as a 1-hour (h) infusion in combination with low dose irinotecan in patients (pts) with relapsed/refractory Ewing sarcoma (ES).

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.11508

N/A

0DataRank · unranked

13 citations

Karla V. Ballman, Rachel S. Heise, Leo Mascarenhas, John Glod, Mary Frances Frances Wedekind +14 more

CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer

UNC Libraries(2024)10.17615/yzyb-1s66

N/A

0DataRank · unranked

0 citations

L.A. Carey, M.G. Soloway, C.M. Perou, P.A Spears, Terry Hyslop +26 more

Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials

UNC Libraries(2024)10.17615/6kd2-qh45

N/A

0DataRank · unranked

0 citations

A Fernandez-Martinez, Françoise Rothé, EP Winer, David Venet, I.E. Krop +17 more

Extracellular iron and the lung microbiome in smoking and COPD

ERJ Open Research(2025)10.1183/23120541.00019-2025

N/A

0DataRank · unranked

0 citations

Christina D. Campbell, Katherine Hoffman, James J. Butler, Kristopher Opron, John R. Erb‐Downward +28 more

CODEL: phase III study of RT, RT + TMZ, or TMZ for newly diagnosed 1p/19q codeleted oligodendroglioma. Analysis from the initial study design

Neuro-Oncology(2020)10.1093/neuonc/noaa168

N/A

0DataRank · unranked

116 citations

Karla V. Ballman, Martin J. van den Bent, Caterina Giannini, Evanthia Galanis, Paul D. Brown +18 more

Final report from Intergroup NCCTG 86-72-51 (Alliance): a phase III randomized clinical trial of high-dose versus low-dose radiation for adult low-grade glioma

Neuro-Oncology(2020)10.1093/neuonc/noaa021

N/A

0DataRank · unranked

59 citations

S. Keith Anderson, Xiomara W. Carrero, Paul D. Brown, Karla V. Ballman, Brian Patrick O’Neill +8 more

Efficacy of osimertinib against EGFRvIII+ glioblastoma

Oncotarget(2020)10.18632/oncotarget.27599

N/A

0DataRank · unranked

57 citations

Shawn G. Kwatra, Cory Nanni, Callie Roberts, S. Phillips, Sarah Nullmeyergh +13 more

Increased airway iron parameters and risk for exacerbation in COPD: an analysis from SPIROMICS

Scientific Reports(2020)10.1038/s41598-020-67047-w

N/A

0DataRank · unranked

28 citations

Clara Oromendia, Sarah Ann Kikkers, James J. Butler, Sarah L. O’Beirne, Kihwan Kim +23 more

Guidelines for Statistical Reporting in Medical Journals

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.08.019

N/A

0DataRank · unranked

28 citations

Jennifer Le‐Rademacher, Karla V. Ballman, Alex A. Adjei, Sumithra J. Mandrekar, Fang‐Shu Ou

Role of Specialized Composition of SWI/SNF Complexes in Prostate Cancer Lineage Plasticity

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.03.06.949131

N/A

0DataRank · unranked

27 citations

Anke Augspach, Maria Rosaria De Filippo, Davide Prandi, Phillip Thienger, Matteo Benelli +25 more

Dose-escalation results of a phase I study of 225Ac-J591 for progressive metastatic castration resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.114

N/A

0DataRank · unranked

24 citations

Joseph R. Osborne, Muhammad Junaid Niaz, Shankar Vallabhajosula, Panagiotis J. Vlachostergios, Charlene Thomas +9 more

PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.tps760

N/A

0DataRank · unranked

13 citations

Karla V. Ballman, Atish D. Choudhury, Ronald C. Chen, Colleen Watt, Yujia Wen +7 more

Phase I dose-escalation study of PSMA-targeted alpha emitter 225Ac-J591 in men with metastatic castration-resistant prostate cancer (mCRPC).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5560

N/A

0DataRank · unranked

10 citations

Joseph R. Osborne, Escarleth Fernandez, Charlene Thomas, Muhammad Junaid Niaz, Amy Ciriaco +10 more

PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps5100

N/A

0DataRank · unranked

9 citations

Karla V. Ballman, Atish D. Choudhury, Ronald C. Chen, Colleen Watt, Yujia Wen +8 more

ABC trial (A011502): A randomized phase III double-blinded placebo-controlled trial of aspirin as adjuvant therapy breast cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps600

N/A

0DataRank · unranked

5 citations

Eric P. Winer, Karla V. Ballman, Ann H. Partridge, Lisa A. Carey, Margaret Carvan +6 more

Designing Therapeutic Clinical Trials for Older and Frail Adults With Cancer: U13 Conference Recommendations

UNC Libraries(2020)10.17615/a3ca-3a75

N/A

0DataRank · unranked

0 citations

Arti Hurria, Richard L. Schilsky, Harvey J. Cohen, Kenneth E. Schmader, Karla V. Ballman +7 more

Cognitive function in older women with breast cancer treated with standard chemotherapy and capecitabine on Cancer and Leukemia Group B 49907

UNC Libraries(2020)10.17615/csgw-fq68

N/A

0DataRank · unranked

0 citations

Harvey Jay Cohen, Nancy L. Keating, Jeanne S. Mandelblatt, Hyman B. Muss, Arti Hurria +7 more

Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301): Social support in older breast cancer patients

UNC Libraries(2020)10.17615/wphq-zj46

N/A

0DataRank · unranked

0 citations

Aminah Jatoi, Ajeet Gajra, Julie R. Gralow, Antonio C. Wolff, Judith O. Hopkins +7 more

Using ePrognosis to estimate 2-year all-cause mortality in older women with breast cancer: Cancer and Leukemia Group B (CALGB) 49907 and 369901 (Alliance A151503)

UNC Libraries(2020)10.17615/sp3k-3237

N/A

0DataRank · unranked

0 citations

Eric P. Winer, Heidi D. Klepin, Harvey Jay Cohen, Karla V. Ballman, Andrew Artz +14 more

Patterns of Local-Regional Management Following Neoadjuvant Chemotherapy in Breast Cancer: Results From ACOSOG Z1071 (Alliance)

UNC Libraries(2020)10.17615/vv76-g942

N/A

0DataRank · unranked

0 citations

Thomas A. Buchholz, Bruce G. Haffty, Reshma Jagsi, Sarah A. McLaughlin, Karla V. Ballman +4 more

PDIGREE: An adaptive phase III trial of PD-inhibitor nivolumab and ipilimumab (IPI-NIVO) with VEGF TKI cabozantinib (CABO) in metastatic untreated renal cell cancer (Alliance A031704).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.6_suppl.tps366

N/A

0DataRank · unranked

26 citations

Karla V. Ballman, Atish D. Choudhury, Ronald C. Chen, Colleen Watt, Yujia Wen +8 more

P10015/SARC033: A phase 2 trial of trametinib in patients with advanced epithelioid hemangioendothelioma (EHE).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11503

N/A

0DataRank · unranked

10 citations

Karla V. Ballman, Kristen Ganjoo, Elizabeth J. Davis, Jeffrey A. Morgan, Gabriel Tinoco +15 more

Surveillance Imaging vs Symptomatic Recurrence Detection and Survival in Stage II-III Breast Cancer (AFT-01)

JNCI Journal of the National Cancer Institute(2022)10.1093/jnci/djac131

N/A

0DataRank · unranked

12 citations

Heather B. Neuman, Menggang Yu, David J. Vanness, Yajuan Si, Elizabeth S. Burnside +25 more

Characterizing COPD Symptom Variability in the Stable State Utilizing the Evaluating Respiratory Symptoms in COPD Instrument

Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation(2022)10.15326/jcopdf.2021.0263

N/A

0DataRank · unranked

5 citations

Kayley Ancy, Clara Oromendia, Katherine L. Hoffman, Imaani Easthausen, Nancy Kline Leidy +16 more

Randomized phase II/III trial of veliparib or placebo in combination with adjuvant temozolomide in newly diagnosed glioblastoma (GBM) patients with MGMT promoter hypermethylation (Alliance A071102).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.2001

N/A

0DataRank · unranked

18 citations

Karla V. Ballman, Sani H. Kizilbash, Erik P. Sulman, Caterina Giannini, Sandeep H. Mashru +11 more